Elias Sayour, MD, PhD - Research

Research at a glance

Top areas of exploration

Glioblastoma , 12 publications
Immunotherapy , 11 publications
Brain Neoplasms , 10 publications
T-Lymphocytes , 7 publications

Research activity

56 publications

2,148 citations

Why is this important?

Focus

Active clinical trials

PBTC-060

Patients will receive a vaccine called SurVaxM on this study. While vaccines are usually thought of as ways to prevent diseases, vaccines can also be used to treat cancer. SurVaxM is designed to tell the body's immune system to look for tumor cells鈥�

Investigators: Elias Sayour, Jennifer F King
Status: Accepting Candidates
Ages: 1 Year - 21 Years
Sexes: All

My publications

56 publications

2022

The current landscape of immunotherapy for pediatric brain tumors.

Nature cancer

鈥�

2021

Canine osteosarcoma checkpoint expression correlates with metastasis and T-cell infiltrate.

Veterinary immunology and immunopathology

鈥�

2021

GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma 鈥� assessing tumor and T cell interaction

Translational Oncology

鈥�

2021

Nanoparticles as immunomodulators and translational agents in brain tumors

Journal of Neuro-Oncology

鈥�

2021

Optimizing T Cell-Based Therapy for Glioblastoma.

Frontiers in immunology

鈥�

网红黑料

Research at a glance

Top areas of exploration

Research activity

Focus

Active clinical trials

My publications

Filter publications

The current landscape of immunotherapy for pediatric brain tumors.

Canine osteosarcoma checkpoint expression correlates with metastasis and T-cell infiltrate.

GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma 鈥� assessing tumor and T cell interaction

Nanoparticles as immunomodulators and translational agents in brain tumors

Optimizing T Cell-Based Therapy for Glioblastoma.